Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Bullboard Posts
Post by RetailRubeon Sep 16, 2010 12:06pm
254 Views
Post# 17456081

Growthworks exercised options

Growthworks exercised optionsInsider trading reports show two Growthworks Funds exercised stock options on Sept 8th, paying 22 cents for a total of 150,000 shares.  They also let some of their 22 cents options expire.  I assume this transaction was because the options were reaching expiry date and not because Growthworks had some cash inflow from subscribers to invest.

It is possible that Growthworks is now trying to sell the shares at around 39 cents to show a profit of $25,000 to include in their Sept quarter results.  However, they don't want to drop the price much because it would cause a mark-to-market loss on their existing investment.

If there were lots of buying interest in SDI, this wouldn't matter.  However, so far, the NY pitch has not created any huge buying interest.  So any selling pressure is unhelpful.

Bullboard Posts